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Abstract
Background: Beside their established function in shaping cell architecture, some cell polarity proteins were proposed to
participate to lymphocyte migration, homing, scanning, as well as activation following antigen receptor stimulation.
Although PALS1 is a central component of the cell polarity network, its expression and function in lymphocytes remains
unknown. Here we investigated whether PALS1 is present in T cells and whether it contributes to T Cell-Receptor (TCR)-
mediated activation.
Methodology/Principal Findings: By combining RT-PCR and immunoblot assays, we found that PALS1 is constitutively
expressed in human T lymphocytes as well as in Jurkat T cells. siRNA-based knockdown of PALS1 hampered TCR-induced
activation and optimal proliferation of lymphocyte. We further provide evidence that PALS1 depletion selectively hindered
TCR-driven activation of the transcription factor NF-kB.
Conclusions: The cell polarity protein PALS1 is expressed in T lymphocytes and participates to the optimal activation of NF-
kB following TCR stimulation.
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Introduction
Establishment and maintenance of cell polarity is chiefly
orchestrated by a tightly regulated interplay between three
multi-protein complexes: i) Scribble (SCRIB)/Discs Large
(Dlgh1)/Lethal giant larvae (Lgl) complex, ii) partitioning-defective
(PAR) 3 and PAR6/ atypical protein kinase C (aPKC) complex,
and iii) Crumbs (CRB)/ Protein Associated with Lin Seven 1
(PALS1)/ PALS1-associated tight junction protein (PATJ) com-
plex [1,2]. However, each complex is not exclusive, as PAR6 links
PALS1 to PAR3/PAR6/aPKC [3]. In T lymphocytes, cell
polarity proteins were shown to partition the leading edge from
the uropod at the cell rear, and therefore participate to cell
migration, homing, and scanning [4,5,6]. In addition, SCRIB and
Dlgh1 are transiently recruited to the nascent immunological
synapse formed with an antigen-presenting-cell (APC) [4]. Their
depletion in lymphocytes has been associated with an alteration of
antigen receptor-mediated activation [7,8,9,10].
The adaptor PALS1 is crucial for cellular architecture as it
maintains the apico-basal polarity in epithelial cells and authorizes
indirect interactions between CRB and PATJ [11,12]. Interestingly,
Dlgh1 and PALS1 share a COOH-terminal part composed of a
PSD-95/Dlg/ZO-1 (PDZ) domain followed by an SH3 domain
adjacent to an inactive Guanylate kinase(GK) homology region [2].
This unique sequence of PDZ/SH3/GK defines the so-called
membrane-associated guanylate kinase (MAGUK) proteins family,
a group ofmolecules that serveasscaffoldstoorganize multi-protein
signalosomes through their protein-protein interaction domains
[13]. For example, the MAGUK-containing CARMA1 emerges as
a central regulator of lymphocytes activation and proliferation
downstream of antigen receptor stimulation [14]. Indeed,
CARMA1 operates as scaffold to recruit the heterodimer BCL10/
MALT1 (CBM complex), a key step for conveying NF-kB signaling
[14,15,16]. In addition to its established role in polarity, Dlgh1 was
shown to modulate lymphocyte proliferation upon T-cell receptor
ligation, possibly through p38 recruitment or via the transcription
factor NF-AT [9,10,17,18].
Although the MAGUK PALS1 plays a central role in the
establishment of cell polarity, its contribution to lymphocyte
activation remains elusive [8]. Here we show that PALS1 mRNA
and protein is expressed in human lymphocytes. Furthermore,
knocking down of PALS1 with small interfering RNAs (siRNAs)
led to a decreased proliferation of human T lymphocytes, resulting
from a reduced activation of the transcription factor NF-kB.
Results and Discussion
PALS1 expression in T lymphocytes
Although several cell polarity proteins have been characterized
in lymphocytes [4,5], PALS1 expression in T cells remains to be
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PCR analysis on resting human CD3
+ Tc e l l sa n dJ u r k a t
lymphocytes extracts, and detected mRNA for PALS1
(Figure 1A). These mRNA were efficiently translated into
protein, as antibodies against PALS1 detected a band, which
was absent from PALS1-siRNA transfected primary T lympho-
cytes lysates (Figure 1B). Similar results were obtained with
Jurkat T cells (Figure 1B). Of note, PALS1 levels remained
unchanged in cells stimulated with antibodies to CD3 and CD28,
or with PMA and ionomycin (Figure 1C). We next investigated
PALS1 subcellular location by confocal microscopy. In contrast
to epithelial cells where it accumulate to tight junctions [12],
PALS1 did not reach membrane domains and remains essentially
cytosolic with punctuate structures. Additional staining revealed
that these structures coalesced with the Golgi apparatus
(Figure 1D and Figure S1). Accordingly, Brefeldin A-triggered
disassembly of the Golgi apparatus also disrupted PALS1
punctuate structures (Figure 1D). This is reminiscent of PALS1
relocation to the Golgi apparatus in cells infected with SARS
coronovirus [19]. Last, we observed that TCR-mediated
stimulation only promoted a discrete redistribution of PALS1
within the cytosol of Jurkat cells (Figure S1). Altogether, our
results suggest that similarlyt oD l g h 1 ,S C R I B ,C R B 3 ,a n dP K C f
[4,5], the cell polarity protein PALS1 is expressed in lymphocytes
at both mRNA and protein level.
Requirement of PALS1 for optimal T cell activation and
proliferation
Because SCRIB and Dlgh1 were proposed to modulate
lymphocyte proliferation [7,8,9,10], we evaluated whether PALS1
might also participate to T cell activation. To this end, peripheral
blood lymphocytes (PBL) were purified on Ficoll-isopaque
gradients. Primary human T cells were nucleofected for three
days with siRNA targeting PALS1, prior stimulation with anti-
CD3 and anti-CD28 antibodies. PALS1 knockdown led to a
significant decrease in TCR-mediated induction of the activation
markers CD69 and CD25 on cell surface (Figure 2A, B). This was
accompanied by a reduction in Carboxyfluorescein Succinimydyl
Ester (CFSE) dilution, which reflects cell proliferation (Figure 2C).
Collectively, these data suggest that PALS1 participates to the
optimal lymphocyte activation and subsequent proliferation upon
TCR stimulation.
Role of PALS1 in TCR-mediated signaling
To further explore how PALS1 impacts on lymphocyte
proliferation, early signaling pathways emanating from the TCR
were examined in Jurkat cells transfected with PALS1 siRNA. We
did not detect major alteration in the general pattern of tyrosine
phosphorylation, or mitogen-activated protein kinase (MAPK)
extracellular signal-regulated kinases (ERK) 1/2 phosphorylation
upon TCR stimulation (Figure 3A). Only a slight but consistent
increase in TCR-mediated phosphorylation of p38 was noted
(Figure 3A). Moreover, CD3-induced calcium mobilization was
largely normal in PALS1-knockdown Jurkat cells (Figure 3B).
We next analyzed TCR-mediated activation of NF-AT and NF-
kB transcription factors. siRNA-treated Jurkat T cells were co-
transfected with firefly luciferase constructs driven by NF-AT or
NF-kB binding sequences and with a renilla luciferase control.
PALS1 knockdown had only a marginal effect on NF-AT activity
following stimulation with PMA and ionomycin, or with
antibodies to CD3 and CD28 (Figure 3C and Figure S2). In
sharp contrast, NF-kB activity was significantly reduced without
PALS1 (Figure 3D). Interestingly, tumor necrosis factor-a (TNFa)-
induced NF-kB activation remained essentially unaffected,
underscoring the selective involvement of PALS1 in the TCR-
NF-kB pathway (Figure S3). Altogether, our data unveiled an
unexpected role for PALS1 in TCR-mediated NF-kB activation.
PALS1 participates to the optimal activation of NF-kB
upon TCR stimulation
To gain insights on how PALS1 modulate NF-kB, we first
investigated the transcription factor binding ability by electropho-
retic mobility shift assay (EMSA). Less NF-kB bound to its specific
probe in nuclei extracts from PALS1–siRNA transfected cells
following TCR stimulation (Figure 4A). As expected, Oct-1
binding remained unchanged without PALS1. Consistent with a
diminished NF-kB activity, both the phosphorylation and
Figure 1. Expression of the cell polarity protein PALS1 in
human T lymphocytes. A, Analysis of PALS1 mRNA in primary
human T lymphocytes, and Jurkat cell line by Reverse Transcriptase
Polymerase Chain Reaction (RT-PCR). B, Immunoblot analysis of PALS1
in cell lysates from human T lymphocytes and from Jurkat cells. The
specificity of PALS1 antibodies was validated with lysates from cells
transfected with siRNA against PALS1. Tubulin was used as a loading
control. C, Immunoblot analysis of cell extracts from Jurkat cells
stimulated as indicated with 1 mg.ml
21 anti-CD3 and anti-CD28, or with
40 ng.ml
21 PMA together with 300 ng.ml
21 ionomycin (P/I). GAPDH
served as a loading control. D, Confocal microscopy pictures of PALS1
and 58K Golgi protein in Jurkat T lymphocytes either untreated or
incubated with 10 mg.ml
21 Brefeldin A (BFA).
doi:10.1371/journal.pone.0018159.g001
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were severely decreased in the absence of PALS1 (Figure 4B).
Because TCR-induced NF-kB activation relies on the assembly of
the CBM complex [15], BCL10 was immunoprecipitated from
nonspecific (NS-) and PALS1-siRNA transfected Jurkat cells.
MALT1, which forms an heterodimer with BCL10, coprecipitated
with BCL10 regardless of stimulation. Although PALS1 was not
found bound to BCL10, its absence diminished CARMA1
recruitment (Figure 4C, and data not shown). Hence, our data
suggest that PALS1 participates to the optimal translocation and
activation of NF-kB upon TCR stimulation, possibly by favoring
the CBM assembly.
Role of PALS1-associated proteins during TCR-mediated
NF-kB
Since PALS1 nucleates a ternary complex containing CRB3 and
PATJ, and further binds PAR6 to maintain cell polarity [3,20,21],
their contribution to TCR-mediated NF-kB was evaluated. Similarly
to PALS1, mRNA for PATJ, CRB3, PAR6, were efficiently detected
by RT-PCR (Figure 5A). The same hold true for the unrelated cell
polarity protein SCRIB (Figure 5A). siRNA-based knockdown of
PALS1 and CRB3 significantly decreased NF-kB activation in cells
treated by antibodies against CD3 and CD28, or with a mixture of
PMA and ionomycin. Although less dramatic, similar results were
observed with PAR6 or PATJ knockdown. By contrast, NF-kBw a s
normally activated in the absence of SCRIB (Figure 5B). In
agreement, IkBa phosphorylation was diminished in lysates from
CRB3-depleted cells, and to a lesser extent from PATJ- or PAR6-
siRNA transfected cells, and not from SCRIB-depleted cells. Again,
ERK phosphorylation occurred normally (Figure 5C, D, E, and F).
Altogether, our data suggest that PALS1 implication intheTCR-NF-
kB pathway is inextricably linked to its cell polarity partners.
In summary, our data show that the cell polarity protein PALS1
is expressed in lymphocytes and contributes to their optimal
activation. Although Dlgh1 and SCRIB were proposed to
modulate NF-AT or p38 [9,10,17,18] and NF-AT [7] respectively,
a distinct scenario likely occurs for PALS1. Our results support a
model in which PALS1 participates to NF-kB activation, upstream
of IkBa phosphorylation and degradation. However, how precisely
PALS1 modulates NF-kB remains unclear. Because MAGUK
function as scaffold units to organize and integrate multi-molecular
signaling complexes [13], it is tempting to speculate that PALS1
nucleates its own signalosome. For example, CARMA1 anchors a
.900 kDa complex including the heterodimer BCL10/MALT1
[22], and Dlgh1 was reported to bind to Lck, Zap70, Wasp [17],
and p38 [10]. In our hands, PALS1 did not integrate the CBM,
but its absence reduced CARMA1 binding to BCL10. It will
therefore be interesting to identify PALS1 partners in the context
of lymphocyte activation. In line with this, CRB3, PATJ and
PAR6, which all bound PALS1 to maintain cell polarity [2], also
participate to NF-kB signaling upon TCR ligation in lymphocytes,
and might therefore complex with PALS1 in lymphocytes.
Altogether, our results strengthen the unexpected function of cell
polarity proteins in lymphocyte proliferation [7,8,9,10], and unveil
an original role for PALS1 during TCR-mediated NF-kB
activation.
Materials and Methods
Cell culture and reagents
Jurkat T cells E6.1 were purchased from ATCC. CD3
+ human
T lymphocytes from healthy donors (Etablissement Francais du
Sang) were isolated with the MidiMacs system (Miltenyi Biotec).
Cells were activated with a mixture of soluble anti-CD3e (HIT3a,
BD Biosciences) and anti-CD28 (BD Biosciences), or with 20–
40 ng.ml
21 phorbol 12-myristate 13-acetate (PMA, Sigma) and
300 ng.ml
21 ionomycin (Calbiochem). Carboxyfluorescein Succi-
nimydyl Ester (CFSE) and Brefeldin A were purchased from
Sigma, and the calcium-sensitive dye Fluo-4 was from Invitrogen.
Cell lysates preparation, immunoprecipitations, and
immunoblots
Cells were washed twice with PBS 1X and lysed with 50 mM
Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% Igepal, 2 mM
EDTA, supplemented with complete protease inhibitors (Roche).
Lysates were cleared by a centrifugation at 10,000g at 4
oC, and
protein concentration determined (micro BCA kit, Pierce).
Samples were resolved on 5–20% SDS-PAGE gels and transferred
to nitrocellulose membranes (Amersham). For Immunoprecipita-
tions, samples were precleared with protein G-sepharose beads
(Roche) for 30 min prior to overnight incubation with antibodies
and additional protein G-sepharose beads at 4uC, as previously
Figure 2. PALS1 requirement for optimal activation and proliferation in lymphocytes. A and B, Human peripheral blood T lymphocytes
were transfected with siRNA for PALS1 or nonspecific (NS) siRNA. Three days later, cells were stimulated with 1 mg.ml
21 anti-CD3 and anti-CD28. CD69
and CD25 induction at the cell surface were examined 6 hours and 16 hours post-stimulation, respectively. C, Cells as in (A) were loaded with
Carboxyfluorescein Succinimidyl Ester (CFSE), and stimulated with 1 mg.ml
21 anti-CD3 and anti-CD28 for 72 hours. The percentage of CD69- and
CD25-positive cells, and of dividing cells, is shown. These data are representative of four independent experiments.
doi:10.1371/journal.pone.0018159.g002
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(B-12), Tubulin (TU-02), PALS1 (H-250), SCRIB (C-6), PAR6 (G-
9) and p65 (C-20) were purchased from Santa Cruz. Phospho-
specific antibodies against IkBa, ERK, p38, and antibodies to
CARMA1 and to ERK were from Cell Signaling Technologies.
Anti-phosphorylated Tyrosine (4G10, Millipore), anti-GAPDH
(Sigma), and Immobilon (Millipore) chemiluminescent substrates
were also used.
Luciferase assays
Firefly luciferase constructs downstream of promoters for NF-
kB or NF-AT were co-transfected with renilla luciferase pRL-TK
(Int
-) plasmid (Promega). Luciferase activities were analyzed using
the Dual-Luciferase Kit (Promega), with firefly fluorescence units
normalized to renilla luciferase fluorescence units (BMG micro-
plate reader).
siRNA and transfections
All siRNA used were from Invitrogen (Stealth). PALS1.1, 59-
CCAAGGAAACAGUAAUCCAUGUAAA-39; PALS1.2, 59-GA-
GGAGAUCUUAACCUAUGAGGAAA-39; PALS1.3, 59-CAG-
AACAAUGGCCACUACUUUGAUA-39; CRB3, 59-CCAUCA-
CUGCUAUCAUCGUGGUCUU-39; PATJ, 59-GCAUGAAU-
UUCUGACUCCUAGAUUG-39; SCRIB, 59-UGGGAGGCAA-
CGAUCUGGAAGUGCU-39; PAR6 59-GAGCGGGUUCCAG-
GAAUCUUCAUCU-39. Jurkat cells were transfected by electro-
poration with a BTX ECM 830 apparatus (BTX, Harvard
Apparatus), as previously described [16]. For primary cells, PBL
Figure 3. Role of PALS1 on early TCR-mediated signaling. A, Jurkat cells were transfected with nonspecific (NS)- and PALS1-siRNA, and left
three days prior stimulation with 1 mg.ml
21 anti-CD3 and anti-CD28 for 0, 10, 20, and 30 min. Cell lysates were prepared and immunoblots were
performed as indicated. GAPDH, and p65 served as loading controls. Five other experiments provided same results. B, NS- and PALS1-siRNA
transfected Jurkat cells were loaded with the calcium-sensitive dye Fluo-4 and stimulated with 1 mg.ml
21 anti-CD3 (closed symbol), or with 1 mg.ml
21
ionomycin (open symbol). Shown is the mean 6 s.d. of triplicate measurements (one out of two independent experiments). C, D, Jurkat lymphocytes
were transfected with NS- or with three individual siRNA sequences targeting PALS1. After three days, cells were co-transfected with siRNA and with
NF-AT or NF-kB firefly luciferase reporter gene together with a control Renilla plasmid for an additional 24 hours. Cells were then stimulated with 20
or 40 ng.ml
-1 PMA and 300 ng.ml
21 ionomycin (P/I), or 0.5 mg.ml
21 anti-CD3 and anti-CD28. Histograms represent the mean 6 s.d. of triplicate
experiments. RLU, relative light units. The inset immunoblot shows the level of PALS1 knockdown. Data shown are representative of at least five
independent experiments.
doi:10.1371/journal.pone.0018159.g003
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siRNA. Three days later, cells were stimulated with 1 mg.ml
21 anti-CD3 and anti-CD28 for 0, 45, and 90 min. Nuclear extracts were prepared to analyze
the binding of NF-kB and Oct-1 by electrophoretic mobility shift assays (EMSA) with specific probes (closed circles). Free probe is also indicated (open
circles). B, Cells as in (A) were stimulated with 1 mg.ml
21 anti-CD3 and anti-CD28 for 0, 10, 20, and 30 min. Cell extracts were prepared and
immunoblots were performed as indicated. C, Cells as in (A) were stimulated with 1 mg.ml
21 anti-CD3 and anti-CD28 for 0, 10, 20 min. BCL10 was
immunoprecipitated (IP) from cell lysates, and the binding of CARMA1, and MALT1 was assessed by immunoblot. Data shown are representative of at
least three independent experiments.
doi:10.1371/journal.pone.0018159.g004
Figure 5. Role of PALS1 cell polarity partners in NF-kB signaling. A, Expression of cell polarity proteins PALS1, CRB3, PATJ, PAR6, and SCRIB
by RT-PCR in Jurkat T lymphocytes. B, Jurkat were transfected with nonspecific (NS)-, CRB3-, PAR6-, PATJ- and SCRIB-siRNA. After three days, cells were
then co-transfected with siRNA and with NF-kB firefly luciferase reporter gene together with a control Renilla plasmid. 24 hours later, cells were
stimulated with 0.5 mg.ml
21 anti-CD3/CD28 or with 20 ng.ml
21 PMA and 300 ng.ml
21 ionomycin (P/I). Shown is the mean 6 s.d. of triplicate
experiments. RLU, relative light units. C–F, Immunoblots as indicated of NS-, CRB3-, PAR6-, PATJ- and SCRIB-siRNA transfected Jurkat cells stimulated
with 1 mg.ml
21 anti-CD3 and anti -CD28 for 0, 10, 20, and 30 min. Data shown are representative of three independent experiments.
doi:10.1371/journal.pone.0018159.g005
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nucleofected with the Nucleofactor system and T cell solution
(Amaxa, program U14), and left for three days in culture medium
prior treatment.
Nuclear protein extraction and electrophoretic mobility
shift assay (EMSA)
4 mg of nuclear extracts from Jurkat cells were examined for
NF-kB- and Oct1-binding activity by electromobility shift assay
(Panomics kit). Samples were resolved on a 6% native polyacryl-
amide DNA retardation gel in 0.5X TBE buffer and analyzed
using a FUJI LA4000 system.
Reverse transcriptase PCR
2 mg of total RNA from purified human blood T cells or Jurkat
were used for the RT-PCR reactions (RNeasy and OneStep kits,
Quiagen). Primers were designed as follows: PALS1: Forward (F),
59-CTCCTTCATGCAACAGACCA-39 and Backward (B), 59-
CACTTTTACTGGCCCACGAT-39; CRB3: F, 59-CACCT-
GCTCCTCGCTACTG-39 and B, 59-CACTGTTTTGCCTT-
CATCCA-39;P A T J :F ,5 9-CAACGAGCATCCTGACTGAA-
39 and B, 59-GGCGTGGTTGTGAGGACTAT-39; PAR6: F,
59-GTTGCCAACAGCCATAACCT-39 and B, 59-CAGGT-
CACTGCTGTCATCGT-39;S C R I B :F ,5 9-CGCAAGGACA-
CACCTCACTA-39 and B, 59-CCTCCTCCTGAGGAC-
TACCC-39.
Confocal microscopy
Cells were left for 10 min on poly-lysine coated slides (Thermo
Scientific) prior fixation with PBS1X containing 4% parafor-
maldehyde. For TCR crosslinking experiments, cells were
incubated with 5 mg.ml
21 anti-CD3 at 4uC for 15 min. After
two washes, cells were incubated with 5 mg.ml
21 of goat anti-
mouse (Jackson) for 20 min either at 4uCo r3 7 uC. To
disassemble Golgi apparatus, cells were treated with 10 mg.ml
21
Brefeldin A for 60 min. Samples were permeabilized with 0.05%
Triton-X100 in PBS1X for 5 min, and non-specific sites blocked
with 10% FCS in PBS1X. Antibodies used were: PALS1
(Millipore), 58K Golgi (Abcam), Alexa-488 conjugated goat
anti-rabbit IgG or Alexa-594 conjugated goat anti-mouse IgG
(Invitrogen). Samples were analyzed using a Leica confocal
microscope SP6.
Cell surface staining
Cells were incubated for 30 min at 4uC with FITC- and PE-
conjugated antibodies against CD25 and CD69 (ImmunoTools)
and the respective isotype controls in PBS containing 0.5% BSA.
After one wash with ice-cold PBS-BSA, cells were analyzed by flow
cytometry with a FACSCalibur (BD Biosciences).
Supporting Information
Figure S1 Impact of stimulation on PALS1 subcellular
location. A, Jurkat were stimulated 30 min with
40 ng.ml
21 PMA and 300 ng.ml
21 ionomycin. Shown are
confocal microscopy pictures of PALS1 and 58K golgi protein.
B, CD3 was crosslinked at the plasma membrane of Jurkat cells
either at 4 or 37uC for 20 min. Micrographs show double staining
for CD3 and PALS1.
(EPS)
Figure S2 PALS1 is dispensable for TCR-mediated NF-
AT activation. Jurkat lymphocytes were transfected with NS- or
with PALS1-siRNA. After three days, cells were co-transfected
with siRNA and with NF-AT firefly luciferase reporter gene
together with a control Renilla plasmid for an additional 24 hours.
Cells were then stimulated with 20 ng.ml
21 PMA and
300 ng.ml
21 ionomycin (P/I), or with 1 mg.ml
21 anti-CD3 and
anti-CD28. Histograms represent the mean 6 s.d. of triplicate
experiments. RLU, relative light units.
(EPS)
Figure S3 Role of PALS1 cell polarity partners on TNFa-
induced NF-kB activation. A, Jurkat were transfected with
nonspecific (NS)-, PALS1-, CRB3-, PAR6-, and PATJ-siRNA for
three days. Cells were then co-transfected with siRNA and with
NF-kB firefly luciferase reporter gene together with a control
Renilla plasmid. 24 hours later, cells were stimulated with
10 ng.ml
21 TNFa for 6 hours. Shown is the mean 6 s.d. of
triplicate experiments. RLU, relative light units.
(EPS)
Acknowledgments
We thank D. Arnoult and J. Gavard for helpful discussions and critical
reading of the manuscript.
Author Contributions
Conceived and designed the experiments: GC NB. Performed the
experiments: GC CD KP EH NB. Analyzed the data: GC CD KP EH
AV NB. Wrote the paper: GC NB.
References
1. Iden S, Collard JG (2008) Crosstalk between small GTPases and polarity
proteins in cell polarization. Nat Rev Mol Cell Biol 9: 846–859.
2. Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D
(2008) Polarity complex proteins. Biochim Biophys Acta 1778: 614–630.
3. Hurd TW, Gao L, Roh MH, Macara IG, Margolis B (2003) Direct interaction of
two polarity complexes implicated in epithelial tight junction assembly. Nat Cell
Biol 5: 137–142.
4. Ludford-Menting MJ, Oliaro J, Sacirbegovic F, Cheah ET, Pedersen N, et al.
(2005) A network of PDZ-containing proteins regulates T cell polarity and
morphology during migration and immunological synapse formation. Immunity
22: 737–748.
5. Real E, Faure S, Donnadieu E, Delon J (2007) Cutting edge: Atypical PKCs
regulate T lymphocyte polarity and scanning behavior. J Immunol 179:
5649–5652.
6. Hawkins ED, Russell SM (2008) Upsides and downsides to polarity and
asymmetric cell division in leukemia. Oncogene 27: 7003–7017.
7. Arpin-Andre C, Mesnard JM (2007) The PDZ domain-binding motif of the
human T cell leukemia virus type 1 tax protein induces mislocalization of the
tumor suppressor hScrib in T cells. J Biol Chem 282: 33132–33141.
8. Krummel MF, Macara I (2006) Maintenance and modulation of T cell polarity.
Nat Immunol 7: 1143–1149.
9. Stephenson LM, Sammut B, Graham DB, Chan-Wang J, Brim KL, et al. (2007)
DLGH1 is a negative regulator of T-lymphocyte proliferation. Mol Cell Biol 27:
7574–7581.
10. Round JL, Humphries LA, Tomassian T, Mittelstadt P, Zhang M, et al. (2007)
Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T
cell receptor signals toward NFAT but not NF-kappaB transcription factors. Nat
Immunol 8: 154–161.
11. Kamberov E, Makarova O, Roh M, Liu A, Karnak D, et al. (2000) Molecular
cloning and characterization of Pals, proteins associated with mLin-7. J Biol
Chem 275: 11425–11431.
12. Roh MH, Makarova O, Liu CJ, Shin K, Lee S, et al. (2002) The Maguk protein,
Pals1, functions as an adapter, linking mammalian homologues of Crumbs and
Discs Lost. J Cell Biol 157: 161–172.
13. Funke L, Dakoji S, Bredt DS (2005) Membrane-associated guanylate kinases
regulateadhesion and plasticity at celljunctions.AnnuRevBiochem 74:219–245.
14. Blonska M, Lin X (2009) CARMA1-mediated NF-kappaB and JNK activation
in lymphocytes. Immunol Rev 228: 199–211.
Role of PALS1 during TCR-Mediated NF-kB Activation
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e1815915. Thome M, Charton JE, Pelzer C, Hailfinger S (2010) Antigen receptor signaling
to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect
Biol 2: a003004.
16. Carvalho G, Le Guelte A, Demian C, Vazquez A, Gavard J, et al. (2010)
Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-
mediated NFkappaB activation. J Cell Sci 123: 2375–2380.
17. Round JL, Tomassian T, Zhang M, Patel V, Schoenberger SP, et al. (2005)
Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft
aggregation, and effector function in T cells. J Exp Med 201: 419–430.
18. Xavier R, Rabizadeh S, Ishiguro K, Andre N, Ortiz JB, et al. (2004) Discs large
(Dlg1) complexes in lymphocyte activation. J Cell Biol 166: 173–178.
19. Teoh KT, Siu YL, Chan WL, Schluter MA, Liu CJ, et al. (2010) The SARS
coronavirus E protein interacts with PALS1 and alters tight junction formation
and epithelial morphogenesis. Mol Biol Cell 21: 3838–3852.
20. Shin K, Straight S, Margolis B (2005) PATJ regulates tight junction formation
and polarity in mammalian epithelial cells. J Cell Biol 168: 705–711.
21. Roh MH, Fan S, Liu CJ, Margolis B (2003) The Crumbs3-Pals1 complex
participates in the establishment of polarity in mammalian epithelial cells. J Cell
Sci 116: 2895–2906.
22. Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, et al. (2007) Malt1
ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 26:
4634–4645.
23. Bidere N, Ngo VN, Lee J, Collins C, Zheng L, et al. (2009) Casein kinase 1alpha
governs antigen-receptor-induced NF-kappaB activation and human lymphoma
cell survival. Nature 458: 92–96.
Role of PALS1 during TCR-Mediated NF-kB Activation
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e18159